Valuation PT Ikapharmindo Putramas Tbk

Stocks

End-of-day quote INDONESIA S.E. Other stock markets 10/08/2026			5-day change	1st Jan Change
200.00 ^IDR	+1.01%		+6.95%	-10.71%

07-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	340,302	411,058	377,364
Change	-	20.79%	-8.2%
Enterprise Value (EV) ¹	445,409	558,217	501,269
Change	-	25.33%	-10.2%
P/E	11.8x	82x	-13.1x
PBR	1.39x	1.67x	1.73x
PEG	3.87x	-1x	0x
Capitalization / Revenue	0.77x	1x	1.04x
EV / Revenue	1.01x	1.35x	1.38x
EV / EBITDA	10.6x	22x	-30.3x
EV / EBIT	14x	31.9x	-20.5x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	2.25	-	-
Rate of return	1.11%	-	-
EPS ²	17.08	2.977	-17.09
Distribution rate	13.2%	-	-
Net sales ¹	441,137	412,069	363,565
EBITDA ¹	41,844	25,345	-16,528
EBIT ¹	31,780	17,514	-24,485
Net income ¹	15,338	5,015	-28,785
Net Debt ¹	105,107	147,159	123,904
Reference price ²	202.00	244.00	224.00
Nbr of stocks (in thousands)	1,684,663	1,684,663	1,684,663
Announcement Date	29/04/24	26/03/25	16/03/26

¹IDR in Million²IDR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PT IKAPHARMINDO PUTRAMAS TBK	-	-	-	-	18.62M
ELI LILLY AND COMPANY	33.6x	12.3x	24.81x	0.58%	1,057B
JOHNSON & JOHNSON	28.84x	-	-	2.07%	625B
ABBVIE INC.	32.43x	7.35x	15.3x	2.81%	435B
ROCHE HOLDING AG	20.47x	4.85x	12.02x	2.72%	363B
NOVARTIS AG	22.14x	5.72x	14.28x	2.8%	296B
ASTRAZENECA PLC	20.58x	4.25x	12.07x	2.07%	249B
AMGEN INC.	25.76x	6.78x	12.06x	2.45%	222B
NOVO NORDISK A/S	13.84x	4.97x	10.44x	3.68%	209B
GILEAD SCIENCES, INC.	-41.37x	5.93x	33.46x	2.47%	165B
Average	17.37x	6.52x	16.80x	2.41%	362.08B
Weighted average by Cap.	24.45x	8.09x	18.31x	1.98%